Target Name: RNA-induced silencing complex
NCBI ID: P24997
Review Report on RNA-induced silencing complex Target / Biomarker Content of Review Report on RNA-induced silencing complex Target / Biomarker
RNA-induced silencing complex
Other Name(s): micro-RNA (miRNA) loading complex | RISC | miRLC

MiRNA Loading Complex Regulates Gene Expression in Eukaryotic Cells

RNA-induced silencing complex (miRNA loading complex) is a protein complex that plays a critical role in the regulation of gene expression in eukaryotic cells. It is composed of several proteins, including miRNA, Argonaute (RISC) factors, and the protein that physically separates them, called the loader protein. The miRNA loading complex is responsible for transporting miRNA from the cytoplasm to the nucleus, where it can then interact with mRNAs to target specific gene expressions for silencing.

One of the key functions of the miRNA loading complex is to recognize and load miRNA onto the mRNAs that it is intended to silence. This process is highly regulated and requires the involvement of several different proteins. The Argonaute protein, which is a key component of the RISC complex, is responsible for recognizing the specific miRNA target in the mRNA. Once the target is recognized, the Argonaute protein forms a complex with the miRNA and begins to pull it towards the cytoplasm.

The miRNA loading complex also involves the involvement of several other proteins, including the T-DNA-binding protein (TBP) and the protein that physically separates the miRNA from the RISC complex, called the loader protein. The TBP protein is responsible for physically separating the miRNA from the RISC complex, allowing it to move through the cytoplasm and interact with the Argonaute protein. The loader protein, which is also known as the P-box domain-containing protein (PDCP), is responsible for recognizing the specific miRNA target in the mRNA and for physically separating the miRNA from the TBP-RISC complex.

Once the miRNA is loaded onto the mRNA, it can then interact with the target mRNA to induce gene expression levels to be silenced. This process is highly regulated and requires the involvement of several different proteins. The miRNA itself contains several regions that can interact with specific mRNAs. For example, one of the well-known miRNA targets is the double-stranded RNA viruses, which have a specific stem-loop structure that can interact with the miRNA.

The miRNA loading complex is a critical regulatory mechanism that plays a role in the control of gene expression in eukaryotic cells. It is a drug target that can be targeted with small molecules, or it can be used as a biomarker to diagnose diseases. The study of miRNA loading complex is also important for understanding the mechanisms of gene regulation and the potential for using these mechanisms for therapeutic purposes.

In conclusion, RNA-induced silencing complex (miRNA loading complex) is a protein complex that plays a critical role in the regulation of gene expression in eukaryotic cells. It is composed of several proteins, including miRNA, Argonaute (RISC) factors, and the protein that physically separates them, called the loader protein. The miRNA loading complex is responsible for transporting miRNA from the cytoplasm to the nucleus, where it can then interact with mRNAs to target specific gene expressions for silencing. The miRNA loading complex is a drug target and can also be used as a biomarker for diagnostic purposes.

Protein Name: RNA-induced Silencing Complex

The "RNA-induced silencing complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA-induced silencing complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RNA18SN5 | RNA28SN5 | RNA45SN5 | RNA5-8SN1 | RNA5-8SN5 | RNA5-8SP2 | RNA5-8SP4 | RNA5-8SP6 | RNA5S1 | RNA5S10 | RNA5S11 | RNA5S12 | RNA5S17 | RNA5S2 | RNA5S3 | RNA5S4 | RNA5S9 | RNA5SP111 | RNA5SP115 | RNA5SP116 | RNA5SP129 | RNA5SP151 | RNA5SP162 | RNA5SP165 | RNA5SP174 | RNA5SP175 | RNA5SP178 | RNA5SP18 | RNA5SP180 | RNA5SP183 | RNA5SP185 | RNA5SP187 | RNA5SP19 | RNA5SP194 | RNA5SP195 | RNA5SP196 | RNA5SP197 | RNA5SP20 | RNA5SP201 | RNA5SP205 | RNA5SP207 | RNA5SP217 | RNA5SP233 | RNA5SP236 | RNA5SP242 | RNA5SP268 | RNA5SP282 | RNA5SP284 | RNA5SP318 | RNA5SP323 | RNA5SP329 | RNA5SP33 | RNA5SP335 | RNA5SP339 | RNA5SP343 | RNA5SP344 | RNA5SP345 | RNA5SP352 | RNA5SP353 | RNA5SP363 | RNA5SP371 | RNA5SP374 | RNA5SP378 | RNA5SP379 | RNA5SP385 | RNA5SP389 | RNA5SP390 | RNA5SP393 | RNA5SP410 | RNA5SP425 | RNA5SP437 | RNA5SP44 | RNA5SP444 | RNA5SP450 | RNA5SP456 | RNA5SP463 | RNA5SP464 | RNA5SP465 | RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP